Clinical Trial Update: Trastuzumab Optimization Trial in Breast Cancer [Phase 3]

View source ↗

Summary

Update on a Phase 3 trastuzumab optimization trial in breast cancer, involving metastatic or locally advanced disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Regione Lombardia | Conditions: Metastatic or Locally Advanced Breast Cancer | Phase 3 | Status: UNKNOWN